Yoshiaki Zaizen
Yoshiaki Zaizen is an expert in Pulmonology at National Kyushu Medical Center (Japan). As of October 2026, ScienceLeadR ranks Yoshiaki Zaizen in the top 1% of experts worldwide for Lung Diseases, Interstitial. Yoshiaki Zaizen has authored 93 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 2 of them ongoing. SLR score: 360 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Medical Imaging - Immunology - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 93
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Progressive Fibrosing Lung Disease Treated With Nintedanib in a Patient With Long-Standing Autoimmune Pulmonary Alveolar Proteinosis: A Case Report. PMID 42542704 — pulmonary alveolar proteinosis, granulocyte-macrophage colony-stimulating factor, lung, macrophages, phenotype, granulocytes, macrophage colony-stimulating factor, therapeutics, lung diseases, vital capacity, colony-stimulating factors, lung diseases, interstitial | Case Rep Pulmonol | 2026 | 0 |
| Expression of melanoma differentiation-associated gene 5 in the epidermis and cutaneous deposition of complement C3 and immunoglobulins in patients with dermatomyositis. PMID 42258456 — dermatomyositis, skin, cells, genes, dermatitis, melanoma, complement c3c, dermis, immunoglobulins, complement c3, epidermis, complement system proteins, dermatofibrosarcoma | PLoS One | 2026 | 0 |
| Association of the lower-lobe volume ratio on three-dimensional computed tomography with disease progression in idiopathic pulmonary fibrosis. PMID 41881894 — idiopathic pulmonary fibrosis, lung, fibrosis, respiratory tract diseases, tomography, disease progression, pulmonary fibrosis, sex, vital capacity | Respir Investig | 2026 | 0 |
| A proposed pathological diagnosis flowchart for adult interstitial lung disease with transbronchial lung cryobiopsy: Position paper from the Japanese research group on diffuse lung disease. PMID 41775096 — lung, biopsy, diagnosis, research, lung diseases, lung diseases, interstitial | Respir Investig | 2026 | 0 |
| Multifocal micronodular pneumocyte hyperplasia in the absence of tuberous sclerosis complex: A case report. PMID 41742906 — sclerosis, alveolar epithelial cells, absenteeism, tomography, pleura, tuberous sclerosis, hyperplasia | Radiol Case Rep | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study to Evaluate the Efficacy Safety and Tolerability of BMS 986278 in Participants With Progressive Pulmonary Fibrosis NCT06025578 — lung, safety, scleroderma, diffuse, sarcoidosis, fibrosis, connective tissue, arthritis, connective tissue diseases, pulmonary fibrosis, arthritis, rheumatoid, therapeutics, lung diseases, tissues, lung diseases, interstitial | Phase 3 | Active not recruiting | 2023 |
| A Study to Evaluate the Efficacy Safety and Tolerability of BMS 986278 in Participants With Idiopathic Pulmonary Fibrosis NCT06003426 — idiopathic pulmonary fibrosis, safety, fibrosis, pulmonary fibrosis | Phase 3 | Active not recruiting | 2023 |
LeadR Networks
Main global connection map